| # | Drug | Count |
|---|---|---|
| 0 | PREDNISOLONE | 10 |
| 1 | PREDNISOLONE ORAL | 10 |
| 2 | PREDNISOLONE ORAL SOLUTION | 10 |
| 3 | ABACAVIR SULFATE | 9 |
| 4 | ATAZANAVIR | 9 |
| 5 | LAMIVUDINE | 8 |
| 6 | RITONAVIR | 8 |
| 7 | ACETAMINOPHEN | 7 |
| 8 | ACYCLOVIR | 7 |
| 9 | ATENOLOL | 7 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SODIUM CHLORIDE, CALCIUM CHLORIDE, AND POTASSIUM CHLORIDE | 1 | 0.0084 |
| 1 | LEVOKETOCONAZOLE | 1 | 0.0013 |
| 2 | FLUTAMIDE | 1 | 0.0010 |
| 3 | ABACAVIR SULFATE | 9 | 0.0009 |
| 4 | OXACILLIN SODIUM | 1 | 0.0009 |
| 5 | PYRIMETHAMINE | 1 | 0.0008 |
| 6 | METHENAMINE HIPPURATE | 1 | 0.0008 |
| 7 | CHLORZOXAZONE | 1 | 0.0008 |
| 8 | ALUMINUM HYDROXIDE AND MAGNESIUM CARBONATE | 5 | 0.0007 |
| 9 | ATAZANAVIR | 9 | 0.0006 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Cortisol Synthesis Inhibitor [EPC] | 1 | 0.0013 |
| 1 | Dihydrofolate Reductase Inhibitor Antimalarial [EPC] | 1 | 0.0008 |
| 2 | Reducing and Complexing Thiol [EPC] | 1 | 0.0004 |
| 3 | Uric Acid-specific Enzyme [EPC] | 1 | 0.0003 |
| 4 | Survival of Motor Neuron 2 Splicing Modifier [EPC] | 1 | 0.0002 |
| 5 | Antiseptic [EPC] | 1 | 0.0002 |
| 6 | Protease Inhibitor [EPC] | 9 | 0.0002 |
| 7 | Provitamin D2 Compound [EPC] | 6 | 0.0002 |
| 8 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 2 | 0.0002 |
| 9 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 8 | 0.0002 |